Healthcare is a dynamic sector with strong, unique long-term drivers and proven resilience to economic volatility. Thanks to in-depth knowledge and experience across all the different subsectors, Kieger has established itself as a holistic specialist Healthcare asset manager.
Sustainability is of paramount importance to Kieger. We integrate ESG criteria into our financial analysis so as to minimise downside risks, maximise upside potential and, more generally, address social and environmental changes that are reshaping the planet. It is our way of contributing to a brighter future for all.
Kieger is a long-standing investor within the DACH region, «Mittelstand» companies, as well as leading Private Equity funds worldwide. We also manage one of the first Private Equity fund of funds dedicated to Healthcare.
Kieger designs and manages diversified Multi Asset portfolios utilising a broad range of asset classes and thematic investment products. Our seasoned team has a long track record in selecting managers to implement innovative strategies with our global partners.
The Covid-19 crisis has a far-reaching impact on economies and societies around the globe. The existence of many companies is under acute threat, and executives have to weigh the interests of different stakeholders when deciding how to best mitigate losses and secure going concern.
One month ago, markets finally took note of COVID-19 and its critical impact on the global economy. Our Healthcare Investment Team recently published a “Thoughts from the street” piece that provides more details about SARSCoV- 2 treatment developments.
As the world grapples with the outbreak of SARS-CoV-2 and people across the world experience dramatic cuts to their freedom of movement, the healthcare sector is racing to find solutions to tackle the current pandemic. How quickly could treatments for COVID-19 realistically become available?